NDRA – endra life sciences inc. (US:NASDAQ)
Stock Stats
News
ENDRA's TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care [Yahoo! Finance]
ENDRA’s TAEUS® Liver Device Demonstrates High-Level Consistency in Clinical Study, Delivering MRI-Level Results at the Point of Patient Care
ENDRA Life Sciences (NASDAQ:NDRA) had its price target lowered by analysts at Ascendiant Capital Markets from $38.00 to $30.00. They now have a "buy" rating on the stock.
Form 4 ENDRA Life Sciences Inc. For: Mar 02 Filed by: Tokman Alexander Y
Form 4 ENDRA Life Sciences Inc. For: Mar 02 Filed by: Jacroux Richard
Form 4 ENDRA Life Sciences Inc. For: Jan 21 Filed by: Harsh Michael
Form 4 ENDRA Life Sciences Inc. For: Jan 21 Filed by: DIGIANDOMENICO ANTHONY
Form 4 ENDRA Life Sciences Inc. For: Jan 21 Filed by: Tokman Alexander Y
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.